 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe PROMO |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Reprints |
| Permissions |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS
Minerva Cardioangiologica 2006 October;54(5):673-7
Copyright © 2006 EDIZIONI MINERVA MEDICA
language: English
Carotid artery stenting: where are we now?
Rabe K., Sievert H.
CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt, Germany
Carotid artery disease is a frequent risk factor for ischemic stroke. Carotid endarterectomy was considered to be the standard treatment for high graded stenosis until carotid artery stenting (CAS) developed with promising results in early series and randomized trials. At present, stenting is supported in patients at high risk for surgery. Randomized trials analyzing low risk patient groups and studying the long-term results of CAS are necessary and partly underway. Although randomized trials are not yet available, current evidence suggests that cerebral protection devices reduce the number of neurological events. This review discusses the results of randomized trials and clinical series.